Business
SNT: 9% revenue growth, 24% EBITDA increase, and strategic R&D spin-off highlight strong results
SNT: 9% revenue growth, 24% EBITDA increase, and strategic R&D spin-off highlight strong results
About this update from Synektik Sa
Revenue grew 9% year-over-year to 681.3 mln PLN, with EBITDA up 24% and net profit up 24%. The group saw strong recurring revenue growth in medical equipment and IT, stable radio-pharmaceuticals EBITDA, and a strategic spin-off of the R&D/cardio business.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.